12119013 Radix codonopsitis, primarily for pharmacy | 06-14 Plant Products

Basic Information

HS Code

12119013

Product Description

Radix codonopsitis, primarily for pharmacy

Product Chinese Description

党参

Declaration Elements

First Unit

Second Unit

Ordinary Tax Rate

Preferential Tax Rate

Export Tax Rate

Vat Rate

Tax Rebate Rate

Consumption Tax Rate

Customs Supervision Conditions

Inspection and Quarantine

Export Analysis

Report Number: No.EX12119013
Report Title: Export Radix codonopsitis, primarily for pharmacy Trade Data Report
Report Format: Digital Version
Delivery Method: Send Online
Order Hotline: 65-85447467

Export Radix codonopsitis, primarily for pharmacy Trade Data Report

Time Limit：Custom Time Period
----Data Source: Big Trade Data DaaS BI System (BTDaaS)

Part Ⅰ Export Radix codonopsitis, primarily for pharmacy Statistics by Country
　1.1 Statistics by Country
　1.2　Export Quantity from China to All Other Countries by Month
　1.3　Export Value from China to All Other Countries by Month

Part Ⅱ Export Radix codonopsitis, primarily for pharmacy Statistics by Province
　2.1 Statistics by Province
　2.2　Export Quantity of Every Province by Month
　2.3　Export Value of Every Province by Month
　2.4　Exports from Every Province to Every Country
　　　2.4.1　Exports Quantity from Every Province to Every Country
　　　2.4.2　Exports Value from Every Province to Every Country

Part Ⅲ Export Radix codonopsitis, primarily for pharmacy Statistics by Trade Method, Shipment and Plant Location
　3.1 Statistics by Trade Method

Part Ⅳ Export Radix codonopsitis, primarily for pharmacy Price of Export and Product Grade
　4.1 Average Price Monthly Distribution
　4.2 Average Price Country Distribution
　4.3 Average Price Province/City Distribution"
　4.4 Average Price Distribution by Trade Mode

Statement：This report is for reference and research purposes of industry-related companies only. Any company is strictly prohibited from using it for commercial purposes or speculation. Without our written consent, no company shall provide all or part of the content of this report to other organizations or individuals, and it is limited to internal research within the company. Without our written authorization, no newspaper, magazine, website, television, or any other media is allowed to copy, broadcast, quote, or publish any text or data in this report. Any violation of this policy will result in legal action to protect our rights, and any disputes arising from this violation shall be borne by the company itself.

Import Analysis

Report Number: No.EX12119013
Report Title: Import Radix codonopsitis, primarily for pharmacy Trade Data Report
Report Format: Digital Version
Delivery Method: Send Online
Order Hotline: 65-85447467

Import Radix codonopsitis, primarily for pharmacy Trade Data Report

Time Limit：Custom Time Period
----Data Source: Big Trade Data DaaS BI System (BTDaaS)

Part Ⅰ Import Radix codonopsitis, primarily for pharmacy Statistics by Country
　1.1 Statistics by Country
　1.2　Import Quantity from China to All Other Countries by Month
　1.3　Import Value from China to All Other Countries by Month

Part Ⅱ Import Radix codonopsitis, primarily for pharmacy Statistics by Province
　2.1 Statistics by Province
　2.2　Import Quantity of Every Province by Month
　2.3　Import Value of Every Province by Month
　2.4　Imports from Every Province to Every Country
　　　2.4.1　Imports Quantity from Every Province to Every Country
　　　2.4.2　Imports Value from Every Province to Every Country

Part Ⅲ Import Radix codonopsitis, primarily for pharmacy Statistics by Trade Method, Shipment and Plant Location
　3.1 Statistics by Trade Method

Part Ⅳ Import Radix codonopsitis, primarily for pharmacy Price of Import and Product Grade
　4.1 Average Price Monthly Distribution
　4.2 Average Price Country Distribution
　4.3 Average Price Province/City Distribution
　4.4 Average Price Distribution by Trade Mode

Statement：This report is for reference and research purposes of industry-related companies only. Any company is strictly prohibited from using it for commercial purposes or speculation. Without our written consent, no company shall provide all or part of the content of this report to other organizations or individuals, and it is limited to internal research within the company. Without our written authorization, no newspaper, magazine, website, television, or any other media is allowed to copy, broadcast, quote, or publish any text or data in this report. Any violation of this policy will result in legal action to protect our rights, and any disputes arising from this violation shall be borne by the company itself.